Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MI › DETROIT › HENRY FORD HEALTH SYSTEM

HENRY FORD HEALTH SYSTEM

NPI: 1134144801 · DETROIT, MI 48202 · General Acute Care Hospital · NPI assigned 07/13/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official DAMSCHRODER, ROBIN controls 14+ related entities in our dataset. Read more

$334.91M
Total Medicaid Paid
9,624,453
Total Claims
8,665,611
Beneficiaries
1030
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialDAMSCHRODER, ROBIN (EVP, FIN AND BUS DEV OFFICER)
NPI Enumeration Date07/13/2006

Related Entities

Other providers sharing the same authorized official: DAMSCHRODER, ROBIN

ProviderCityStateTotal Paid
HENRY FORD HEALTH ST. JOHN HOSPITAL CHICAGO IL $159.41M
HENRY FORD HEALTH PROVIDENCE HOSPITAL NOVI MI $72.76M
HENRY FORD WYANDOTTE HOSPITAL WYANDOTTE MI $60.54M
HENRY FORD HEALTH MACOMB OAKLAND HOSPITAL WARREN MI $59.25M
W.A. FOOTE MEMORIAL HOSPITAL JACKSON MI $41.32M
HENRY FORD MACOMB HOSPITAL CORPORATION CLINTON TWP MI $40.96M
HENRY FORD HEALTH GENESYS HOSPITAL GRAND BLANC MI $31.39M
HENRY FORD HEALTH MACOMB OAKLAND HOSPITAL MADISON HEIGHTS MI $24.76M
HENRY FORD HEALTH SYSTEM WEST BLOOMFIELD MI $19.27M
HENRY FORD HEALTH ROCHESTER HOSPITAL ROCHESTER MI $11.98M
HENRY FORD HEALTH RIVER DISTRICT HOSPITAL EAST CHINA MI $4.59M
W.A. FOOTE MEMORIAL HOSPITAL JACKSON MI $2.11M
HENRY FORD HEALTH PROVIDENCE HOSPITAL NOVI MI $255K
HENRY FORD HEALTH ST. JOHN HOSPITAL DETROIT MI $4K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,326,922 $47.14M
2019 1,318,823 $43.40M
2020 1,159,228 $36.68M
2021 1,469,204 $48.02M
2022 1,521,916 $52.70M
2023 1,540,504 $56.14M
2024 1,287,856 $50.82M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 203,076 185,738 $62.05M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 986,870 805,775 $42.11M
99284 Emergency department visit for the evaluation and management, high severity 129,709 122,870 $22.36M
99283 Emergency department visit for the evaluation and management, moderate severity 173,753 164,725 $20.40M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 121,610 113,173 $12.28M
J9271 Injection, pembrolizumab, 1 mg 1,279 1,006 $6.88M
96361 Intravenous infusion, hydration; each additional hour 129,224 109,944 $6.49M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 76,349 74,300 $5.79M
G0378 Hospital observation service, per hour 20,588 19,000 $5.45M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 46,208 40,411 $4.56M
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg 4,811 4,414 $4.33M
74177 Computed tomography, abdomen and pelvis; with contrast material 30,614 29,964 $3.99M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 33,388 31,865 $3.51M
71046 Radiologic examination, chest; 2 views 85,804 82,408 $3.29M
96375 Therapeutic injection; each additional sequential IV push 100,309 84,677 $3.16M
G0451 Development testing, with interpretation and report, per standardized instrument form 63,325 62,997 $3.10M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 44,220 44,075 $2.95M
99282 Emergency department visit for the evaluation and management, low to moderate severity 40,597 39,076 $2.95M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 17,106 11,938 $2.85M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 39,363 38,568 $2.53M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 7,741 7,682 $2.43M
90460 Immunization administration through 18 years of age via any route, first or only component 104,990 104,009 $2.41M
70450 Computed tomography, head or brain; without contrast material 24,900 24,028 $2.36M
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 4,341 4,254 $2.19M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 98,238 33,322 $1.92M
45380 Colonoscopy, flexible; with biopsy, single or multiple 3,981 3,943 $1.91M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 27,338 27,282 $1.80M
59025 Fetal non-stress test 21,012 7,857 $1.74M
J7300 Intrauterine copper contraceptive (paragard) 1,814 1,806 $1.71M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 6,197 6,165 $1.53M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 3,488 3,452 $1.43M
Q3014 Telehealth originating site facility fee 81,770 66,939 $1.43M
90834 Psychotherapy, 45 minutes with patient 23,418 17,968 $1.36M
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 22,834 22,204 $1.34M
90670 33,619 33,368 $1.34M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 27,452 26,337 $1.30M
74176 Computed tomography, abdomen and pelvis; without contrast material 11,496 11,323 $1.28M
71045 Radiologic examination, chest; single view 32,426 31,132 $1.27M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 119,528 116,455 $1.25M
90677 7,949 7,947 $1.20M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 115,642 112,631 $1.18M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 5,606 5,580 $1.18M
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 17,440 17,181 $1.17M
J0585 Injection, onabotulinumtoxina, 1 unit 3,551 2,148 $1.16M
76830 Ultrasound, transvaginal 19,338 18,740 $1.12M
90651 15,682 15,644 $1.12M
J3380 Injection, vedolizumab, intravenous, 1 mg 332 313 $1.10M
97530 Therapeutic activities, direct patient contact, each 15 minutes 47,106 21,745 $1.08M
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 1,140 1,055 $1.08M
78815 Positron emission tomography (PET) for limited area imaging 1,239 1,233 $1.08M
20610 8,228 6,801 $1.06M
95810 Polysomnography; sleep staging with 4 or more additional parameters 2,062 2,028 $1.05M
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 19,975 19,704 $1.05M
71260 Computed tomography, thorax, diagnostic; with contrast material 8,532 8,436 $1.04M
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 15,245 15,208 $1.04M
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 104,478 89,376 $1.02M
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 22,164 18,999 $988K
70496 5,517 5,419 $916K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 23,880 19,118 $911K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 13,342 13,108 $904K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography 3,603 3,578 $889K
47562 223 218 $889K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 45,819 18,204 $887K
77067 Screening mammography, bilateral, including computer-aided detection 17,527 17,517 $881K
J1745 Injection, infliximab, excludes biosimilar, 10 mg 418 378 $878K
93975 7,457 7,292 $853K
49083 1,762 883 $796K
77386 2,638 244 $778K
90837 Psychotherapy, 53 minutes with patient 13,955 11,104 $761K
80061 Lipid panel 65,093 64,599 $725K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 50,101 19,354 $699K
76705 Ultrasound, abdominal, real time with image documentation; limited 11,703 11,468 $686K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 27,414 26,481 $672K
76801 11,613 10,783 $664K
86900 47,959 45,086 $651K
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg 462 196 $645K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 10,598 9,216 $628K
71275 Computed tomographic angiography, chest, with contrast material 7,317 7,202 $615K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 1,515 1,488 $614K
90750 4,007 4,005 $595K
97161 11,115 11,031 $577K
64635 659 584 $559K
67028 Intravitreal injection of a pharmacologic agent 3,112 2,927 $545K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 8,918 8,903 $543K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 1,567 1,545 $541K
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg 801 796 $540K
90791 Psychiatric diagnostic evaluation 8,582 8,383 $539K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 12,820 5,736 $523K
J0178 Injection, aflibercept, 1 mg 571 538 $509K
64493 969 874 $500K
62323 1,620 1,608 $489K
10060 5,012 4,856 $466K
95811 931 895 $457K
76700 Ultrasound, abdominal, real time with image documentation; complete 6,977 6,957 $437K
43235 1,078 1,070 $408K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 4,236 4,214 $393K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies 434 432 $393K
19083 475 469 $390K
99385 6,043 5,962 $389K
86780 45,362 44,870 $385K
92587 2,725 2,701 $383K
96127 34,129 33,544 $383K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 3,189 3,179 $382K
70491 3,301 3,254 $382K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 3,102 3,092 $380K
70551 Magnetic resonance imaging, brain; without contrast material 2,599 2,581 $379K
72141 2,819 2,807 $378K
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens 41,113 40,030 $366K
17110 8,258 7,467 $336K
96367 9,745 7,531 $330K
77334 771 584 $320K
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 270 245 $316K
90739 1,967 1,963 $315K
99281 Emergency department visit for the evaluation and management, self-limited or minor 7,100 6,721 $307K
31575 3,473 3,393 $306K
74183 1,763 1,745 $304K
80053 Comprehensive metabolic panel 161,393 143,456 $301K
90832 Psychotherapy, 30 minutes with patient 7,361 6,626 $301K
31231 3,349 3,266 $299K
G0008 Administration of influenza virus vaccine 28,715 28,680 $289K
77412 2,112 265 $288K
J7120 Ringers lactate infusion, up to 1000 cc 8,328 7,423 $282K
90732 2,793 2,790 $277K
93971 5,089 4,962 $277K
67228 1,062 921 $277K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 28,483 28,067 $276K
72197 1,071 1,071 $270K
P9016 Red blood cells, leukocytes reduced, each unit 1,971 1,663 $270K
97162 5,176 5,124 $261K
36430 1,652 1,323 $259K
76770 4,431 4,388 $255K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 858 844 $253K
84443 Thyroid stimulating hormone (TSH) 67,775 66,498 $251K
93970 2,391 2,361 $250K
90682 4,294 4,282 $250K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 90,544 87,562 $249K
96415 4,953 3,944 $248K
58301 2,117 2,049 $245K
52000 927 911 $238K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 340,346 298,595 $231K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1,240 867 $231K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 79,264 78,599 $229K
99383 3,453 3,445 $227K
C8928 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report 850 849 $227K
20550 1,834 1,634 $226K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 14,881 14,444 $226K
77336 3,200 1,519 $221K
80048 Basic metabolic panel (calcium, ionized) 240,136 212,893 $220K
90688 18,035 18,002 $217K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 13,443 12,816 $216K
72156 1,675 1,670 $214K
99386 3,305 3,254 $210K
71250 3,758 3,720 $209K
90792 Psychiatric diagnostic evaluation with medical services 4,796 4,627 $209K
64450 876 839 $209K
20553 1,550 1,530 $203K
J1750 Injection, iron dextran, 50 mg 3,502 1,537 $201K
76881 3,775 3,342 $200K
92523 1,774 1,765 $199K
91320 1,875 1,871 $198K
31579 1,006 944 $198K
0001A 5,577 5,577 $197K
77066 Tomosynthesis, mammo 3,209 3,181 $191K
0002A 5,016 5,014 $191K
76642 5,351 5,269 $188K
11900 5,228 4,880 $188K
11104 1,180 1,170 $187K
J9022 Injection, atezolizumab, 10 mg 51 39 $187K
83036 Hemoglobin; glycosylated (A1C) 85,130 84,424 $185K
20611 1,645 1,568 $182K
77065 Tomosynthesis, mammo 3,812 3,625 $173K
64615 1,500 1,479 $169K
94060 1,211 1,192 $168K
95910 1,197 1,193 $167K
93797 2,501 454 $165K
74170 1,801 1,775 $164K
96417 3,781 2,461 $160K
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg 95 73 $156K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 10,250 10,241 $155K
76819 Fetal biophysical profile; without non-stress testing 2,414 1,252 $154K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 2,788 2,772 $153K
72125 Computed tomography, cervical spine; without contrast material 9,520 9,332 $152K
92235 1,143 1,137 $149K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 22,392 22,256 $149K
76536 2,962 2,955 $148K
86832 1,599 1,500 $144K
86833 1,576 1,476 $143K
90716 10,668 10,630 $142K
97165 2,901 2,848 $136K
72158 1,086 1,077 $136K
99382 2,094 2,091 $135K
77063 Screening digital breast tomosynthesis, bilateral 9,991 9,989 $132K
99384 2,015 2,006 $131K
86870 1,006 968 $130K
77300 490 403 $129K
70486 4,767 4,711 $129K
72131 3,749 3,718 $127K
92083 5,082 5,053 $124K
91200 2,042 2,006 $124K
90686 24,997 24,954 $122K
93798 1,918 529 $121K
95909 884 878 $121K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 9,758 9,744 $120K
70487 1,314 1,294 $112K
95911 428 428 $112K
71270 987 967 $111K
J0185 Injection, aprepitant, 1 mg 942 646 $110K
72100 11,151 11,097 $109K
85027 101,925 93,959 $109K
74174 645 638 $109K
99487 Ccm add 20min 1,759 1,279 $107K
44970 28 27 $107K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 129,121 109,262 $104K
80074 12,223 12,140 $104K
92651 1,019 1,010 $102K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 26,200 25,154 $101K
90734 10,738 10,705 $101K
90472 Immunization administration, each additional vaccine (list separately) 8,493 8,455 $100K
96160 6,349 6,344 $98K
87505 2,505 2,482 $96K
29075 810 764 $95K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 3,554 3,549 $95K
11102 997 991 $94K
76882 3,053 2,838 $94K
17250 1,399 1,218 $92K
99381 1,500 1,489 $92K
J7042 5% dextrose/normal saline (500 ml = 1 unit) 1,541 1,270 $92K
90480 2,823 2,814 $91K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 22,131 20,030 $90K
90620 3,189 3,180 $90K
84702 60,355 52,238 $89K
86480 6,576 6,506 $89K
94010 7,756 7,650 $87K
90847 Family psychotherapy with the patient present, 50 minutes 1,623 1,366 $85K
76825 289 287 $84K
J9299 Injection, nivolumab, 1 mg 18 12 $84K
73700 1,743 1,724 $84K
36591 3,388 2,454 $84K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 8,195 7,986 $83K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 47,753 46,779 $82K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring 340 339 $82K
90678 277 277 $82K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 1,752 1,345 $81K
93308 832 820 $81K
82728 27,311 26,596 $79K
94726 1,143 1,139 $79K
95117 3,780 2,168 $79K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 6,659 6,656 $76K
Q0222 Injection, bebtelovimab, 175 mg 187 187 $76K
11100 495 474 $75K
99406 4,881 4,790 $75K
G0260 Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography 240 237 $72K
87808 50,913 49,557 $72K
86803 43,500 43,252 $72K
77080 1,176 1,172 $71K
83970 6,855 6,716 $71K
J7323 Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose 655 336 $71K
J2327 Injection, risankizumab-rzaa, intravenous, 1 mg 13 13 $69K
73221 653 648 $69K
92586 966 959 $68K
G0009 Administration of pneumococcal vaccine 7,075 7,065 $68K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 5,401 5,270 $66K
92550 4,707 4,687 $65K
73562 22,408 22,045 $65K
0124A 2,008 2,007 $63K
85610 113,549 96,678 $62K
58100 676 662 $61K
62270 227 214 $61K
0054A 1,632 1,630 $59K
82607 21,625 21,480 $58K
83550 29,465 28,879 $58K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,265 1,234 $58K
92557 7,872 7,827 $58K
87536 6,146 5,991 $57K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 5,499 5,474 $57K
58300 3,226 3,152 $56K
71271 901 901 $55K
81373 799 799 $55K
97535 Self-care/home management training, each 15 minutes 1,783 1,437 $53K
82947 19,078 18,956 $52K
83655 18,900 18,808 $52K
72128 1,410 1,400 $52K
P9046 Infusion, albumin (human), 25%, 20 ml 553 244 $52K
83013 2,616 2,603 $51K
97166 1,057 1,044 $51K
83735 171,157 141,770 $51K
96411 1,374 965 $51K
86003 4,880 4,734 $50K
88305 Level IV - Surgical pathology, gross and microscopic examination 22,766 22,383 $49K
11056 1,267 1,251 $49K
73030 15,505 15,168 $49K
20600 386 352 $48K
73630 22,756 22,144 $47K
93296 2,487 2,485 $47K
J1729 Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg 588 239 $46K
43264 107 107 $46K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 2,612 2,608 $46K
0071A 1,169 1,169 $45K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,174 1,139 $44K
83540 30,253 29,649 $44K
73130 18,405 17,788 $42K
87522 Neg quan hep c or qual rna 4,088 3,790 $42K
87086 Culture, bacterial; quantitative colony count, urine 58,528 55,975 $42K
29515 550 535 $41K
73610 17,939 17,011 $41K
96161 2,682 2,666 $41K
10061 239 235 $41K
82746 14,710 14,617 $41K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 18,847 16,692 $41K
86235 4,653 4,576 $40K
93017 3,143 3,101 $40K
96132 450 449 $40K
80197 8,584 4,929 $40K
97116 3,473 2,188 $40K
J1726 Injection, hydroxyprogesterone caproate, (makena), 10 mg 195 88 $40K
84403 5,176 5,107 $39K
72050 2,956 2,939 $39K
98941 Chiropractic manipulative treatment; spinal, 3-4 regions 4,533 2,419 $39K
74178 231 231 $39K
69210 3,419 3,308 $38K
82105 10,675 10,404 $37K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring 186 186 $37K
93976 696 679 $37K
84439 16,232 15,726 $37K
95908 280 278 $36K
96416 209 114 $36K
20526 280 251 $36K
96402 1,590 1,499 $35K
87497 3,206 1,807 $35K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 24,964 22,337 $35K
0004A 953 950 $35K
36561 27 25 $35K
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc 801 666 $35K
0072A 886 885 $34K
G0010 Administration of hepatitis b vaccine 2,252 2,248 $34K
92250 8,455 8,218 $34K
90656 2,978 2,976 $33K
82570 28,023 26,647 $33K
82248 90,983 81,135 $32K
86580 3,989 3,866 $32K
87340 23,752 23,541 $31K
12032 242 241 $31K
G0105 Colorectal cancer screening; colonoscopy on individual at high risk 76 76 $31K
19318 14 14 $31K
81370 153 147 $31K
83880 36,114 34,026 $31K
92552 1,447 1,447 $31K
90658 3,414 3,411 $31K
95250 486 473 $28K
92579 1,922 1,897 $28K
91010 135 133 $28K
81025 124,396 118,783 $28K
88342 8,895 8,725 $27K
82043 21,179 20,695 $27K
36415 Collection of venous blood by venipuncture 25,173 22,514 $27K
93922 1,343 1,332 $26K
81376 206 192 $26K
82784 6,893 6,521 $26K
74018 5,275 5,089 $25K
86923 1,921 1,708 $25K
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory 2,047 2,037 $25K
95713 83 82 $25K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results 1,393 1,378 $25K
80076 14,852 13,946 $25K
82670 3,661 3,301 $25K
0052A 651 650 $25K
92136 1,358 1,340 $24K
90461 59,307 58,952 $24K
86762 15,668 15,584 $23K
73502 7,890 7,744 $23K
0051A 617 617 $23K
11721 3,203 3,181 $23K
72070 1,615 1,611 $23K
84146 4,398 4,348 $22K
86360 5,444 5,347 $22K
81001 149,918 141,397 $22K
Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg 21 15 $22K
86160 6,179 6,120 $22K
20605 183 171 $22K
66982 27 26 $22K
70544 477 468 $21K
82951 2,717 2,707 $21K
73110 10,881 10,314 $21K
77301 30 26 $21K
17111 430 408 $21K
86147 1,659 1,642 $21K
72157 206 205 $20K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 16,890 16,667 $20K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring 77 77 $20K
93350 109 108 $20K
83001 4,542 4,233 $20K
96118 349 304 $20K
95700 163 161 $19K
0081A 494 494 $19K
95951 81 77 $19K
72146 149 148 $18K
86593 3,188 3,121 $18K
99215 Prolong outpt/office vis 278 266 $18K
83993 2,099 2,089 $18K
94618 1,508 1,451 $18K
G0390 Trauma response team associated with hospital critical care service 40 40 $18K
86592 5,115 5,025 $18K
J1453 Injection, fosaprepitant, 1 mg 1,180 813 $18K
86140 22,488 20,795 $18K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 65 65 $18K
72040 2,803 2,786 $17K
87517 1,630 1,564 $17K
90935 Hemodialysis procedure with single evaluation by a physician 138 52 $17K
88184 283 266 $17K
70543 61 60 $17K
10005 52 51 $17K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 587 578 $17K
87081 46,601 45,915 $17K
10120 89 88 $16K
11055 557 545 $16K
70498 5,095 5,012 $16K
84460 40,701 39,225 $16K
82565 9,633 9,202 $16K
90662 830 829 $16K
85730 84,335 78,719 $15K
95800 189 189 $15K
84450 9,594 9,473 $15K
86706 8,073 8,000 $15K
95913 53 53 $15K
74022 10,136 9,945 $15K
84425 2,329 2,317 $14K
82465 5,847 4,597 $14K
92134 10,726 10,220 $14K
73560 3,063 2,989 $14K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 209 208 $14K
77338 79 65 $14K
64483 38 37 $14K
87529 3,103 3,060 $14K
86769 635 626 $14K
73521 1,433 1,430 $14K
82677 2,378 2,370 $13K
83516 3,511 3,417 $13K
0082A 342 342 $13K
99495 208 208 $13K
85007 25,235 21,087 $13K
84100 41,603 32,797 $13K
41828 12 12 $13K
11981 253 252 $12K
82247 34,984 32,296 $12K
86255 6,290 6,191 $12K
70480 182 181 $12K
83002 3,011 2,693 $12K
G2214 Initial or subsequent psychiatric collaborative care management, first 30 minutes in a month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional 268 267 $12K
11750 65 52 $12K
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg 18 13 $12K
83721 5,235 5,209 $12K
64405 95 92 $12K
97014 1,517 744 $12K
86704 5,853 5,802 $11K
20680 17 14 $11K
78264 53 53 $11K
43244 12 12 $11K
93750 242 209 $11K
83615 12,235 10,303 $11K
84481 2,258 2,159 $11K
88341 2,282 2,235 $11K
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination 261 259 $11K
97012 1,555 652 $10K
73080 6,031 5,848 $10K
51798 7,116 6,285 $10K
77290 65 61 $10K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 356 354 $10K
81003 67,772 65,803 $10K
72110 880 879 $10K
86039 6,719 6,682 $10K
73564 1,482 1,473 $10K
87799 877 681 $10K
84153 2,160 2,058 $10K
87902 409 402 $10K
99232 Subsequent hospital care, per day, moderate complexity 227 118 $10K
96130 577 574 $10K
83020 10,399 10,243 $9K
87186 12,926 12,609 $9K
G0379 Direct admission of patient for hospital observation care 29 29 $9K
92551 1,116 1,116 $9K
74019 1,563 1,530 $9K
12041 54 53 $9K
73590 7,441 7,231 $9K
87210 22,660 21,786 $9K
73552 3,655 3,599 $9K
86336 2,459 2,450 $9K
82627 1,394 1,387 $9K
92133 6,566 6,531 $9K
43259 24 24 $9K
57454 66 65 $9K
84165 4,664 4,403 $9K
87430 19,248 18,977 $8K
96380 454 453 $8K
73140 4,489 4,407 $8K
87631 4,040 3,989 $8K
86376 2,909 2,892 $8K
72082 258 257 $8K
85652 19,704 18,514 $8K
11982 61 61 $8K
96138 694 692 $8K
0031A 224 224 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 35,547 35,009 $8K
87077 10,485 10,262 $8K
0154A 209 209 $8K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 191 190 $8K
29540 108 107 $8K
80069 4,517 4,257 $8K
73200 156 155 $7K
95816 69 68 $7K
82533 1,457 1,363 $7K
97035 1,199 562 $7K
86696 2,287 2,261 $7K
99233 Prolong inpt eval add15 m 114 57 $7K
72170 2,211 2,180 $7K
92002 120 120 $7K
84445 555 551 $7K
82550 11,916 10,904 $7K
96523 270 256 $7K
29105 88 86 $6K
C1769 Guide wire 4,941 4,717 $6K
82274 733 733 $6K
86200 4,463 4,450 $6K
84156 8,724 7,579 $6K
73100 835 785 $6K
87324 1,538 1,527 $6K
82378 2,014 1,862 $6K
84144 1,255 885 $6K
J0561 Injection, penicillin g benzathine, 100,000 units 82 78 $6K
C9257 Injection, bevacizumab, 0.25 mg 1,469 1,391 $6K
84520 4,129 3,828 $6K
73090 5,367 5,139 $6K
88307 1,163 1,109 $6K
84550 6,518 5,991 $6K
86787 3,253 3,218 $6K
36600 1,849 1,792 $6K
82952 2,599 2,590 $6K
72072 879 874 $5K
Q2036 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) 703 702 $5K
87634 6,275 6,192 $5K
97022 807 318 $5K
84478 115 79 $5K
86850 46,086 43,357 $5K
12051 29 29 $5K
86708 3,037 3,015 $5K
86695 2,288 2,262 $5K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 812 715 $5K
86334 1,169 1,063 $5K
0012A 126 126 $5K
0121A 184 182 $5K
74160 75 73 $5K
99205 Prolong outpt/office vis 50 50 $5K
82330 4,884 4,362 $5K
86665 1,458 1,429 $5K
92025 1,343 1,323 $4K
0074A 167 167 $4K
0011A 134 134 $4K
36592 292 165 $4K
86146 1,397 1,388 $4K
86901 47,822 44,959 $4K
71101 943 935 $4K
86828 481 471 $4K
84484 73,517 64,654 $4K
83690 67,220 62,496 $4K
86431 5,879 5,848 $4K
83014 1,692 1,685 $4K
30140 12 12 $4K
82962 75,659 55,677 $4K
73060 3,018 2,888 $4K
69209 582 551 $4K
86301 1,243 1,169 $4K
82024 296 278 $4K
90675 23 13 $4K
64447 158 155 $4K
92060 884 880 $4K
87329 819 816 $4K
74220 52 52 $3K
0003A 112 112 $3K
84207 523 520 $3K
64415 139 139 $3K
67210 16 15 $3K
99496 50 50 $3K
76831 41 41 $3K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 96 88 $3K
87088 5,288 5,202 $3K
95912 12 12 $3K
0173A 80 80 $3K
97168 92 91 $3K
90744 646 644 $3K
85018 6,218 6,017 $3K
0151A 94 94 $3K
87070 7,940 6,717 $3K
0083A 83 83 $3K
88173 800 778 $3K
93298 167 167 $3K
86765 1,209 1,202 $3K
73000 879 824 $3K
71100 1,908 1,886 $3K
96401 224 136 $3K
90723 30,255 30,039 $3K
83525 682 678 $3K
76857 67 67 $3K
85014 5,704 5,519 $3K
84480 609 594 $3K
29125 2,639 2,552 $3K
76820 4,617 2,330 $3K
86304 536 482 $3K
88112 913 885 $3K
86705 1,635 1,623 $3K
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility 22 12 $3K
M0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring 32 32 $3K
76813 129 123 $3K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 2,244 2,211 $3K
72193 32 31 $3K
97163 64 63 $3K
73501 443 438 $3K
72202 244 244 $3K
S0077 Injection, clindamycin phosphate, 300 mg 740 597 $3K
92020 1,321 1,306 $3K
46600 707 692 $3K
87338 546 545 $3K
88360 183 176 $3K
97164 70 70 $3K
00731 67 58 $3K
C8908 Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral 12 12 $3K
86036 792 791 $3K
90746 37 37 $2K
80164 1,602 1,495 $2K
83921 711 709 $2K
87205 8,301 7,262 $2K
85045 4,159 3,733 $2K
78306 13 12 $2K
88312 741 737 $2K
99492 48 45 $2K
83520 588 571 $2K
85613 1,169 1,161 $2K
82803 27,571 24,724 $2K
88304 2,585 2,560 $2K
82085 1,683 1,675 $2K
90681 15,054 14,911 $2K
70355 292 286 $2K
86694 708 701 $2K
51701 969 949 $2K
12001 3,742 3,703 $2K
73660 1,014 1,005 $2K
87147 5,150 5,092 $2K
G0297 Low dose ct scan (ldct) for lung cancer screening 49 49 $2K
92285 977 876 $2K
83010 1,328 1,181 $2K
51725 13 13 $2K
73620 615 604 $2K
82088 155 154 $2K
82103 1,304 1,295 $2K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring 13 13 $2K
0171A 62 62 $2K
82390 1,292 1,283 $2K
92567 6,360 6,305 $2K
86664 1,448 1,429 $2K
84132 6,135 5,586 $2K
86300 305 274 $2K
82010 9,546 8,230 $2K
57456 14 14 $2K
86038 975 973 $2K
C1773 Retrieval device, insertable (used to retrieve fractured medical devices) 1,161 1,150 $2K
89060 1,841 1,754 $2K
82150 4,844 4,575 $2K
12031 12 12 $2K
82164 989 969 $2K
95806 25 25 $2K
29405 15 12 $2K
J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose 31 16 $2K
20552 13 13 $2K
64400 12 12 $2K
84630 596 592 $2K
99223 Prolong inpt eval add15 m 14 14 $2K
12011 2,508 2,467 $2K
87420 4,789 4,734 $2K
11200 77 77 $2K
86381 375 373 $2K
72195 13 13 $2K
87101 2,296 2,284 $2K
J7060 5% dextrose/water (500 ml = 1 unit) 288 230 $2K
85379 20,802 20,397 $2K
C1729 Catheter, drainage 2,210 2,109 $2K
C1726 Catheter, balloon dilatation, non-vascular 692 683 $2K
85660 817 815 $1K
87040 9,597 9,058 $1K
96119 163 147 $1K
72080 107 105 $1K
99217 32 32 $1K
99464 31 31 $1K
85732 1,087 1,078 $1K
85384 1,115 984 $1K
G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes 34 26 $1K
74230 26 26 $1K
C1889 Implantable/insertable device, not otherwise classified 122 122 $1K
87209 693 671 $1K
11720 202 201 $1K
80177 3,001 2,695 $1K
83605 37,020 32,939 $1K
84134 208 133 $1K
82525 494 478 $1K
90715 19,621 19,558 $1K
83498 345 339 $1K
86644 1,188 1,160 $1K
95819 14 13 $1K
90647 29,971 29,775 $1K
82140 1,779 1,687 $1K
92611 26 26 $1K
76821 1,566 822 $1K
86225 750 738 $1K
17000 133 131 $1K
90853 Group psychotherapy (other than of a multiple-family group) 26 14 $1K
73070 394 378 $1K
90380 207 207 $1K
70481 12 12 $1K
51702 94 89 $1K
84244 157 156 $1K
99401 27 27 $1K
84300 1,312 1,245 $987.73
70360 748 743 $980.08
0172A 26 26 $965.13
64445 28 26 $957.25
88261 16 16 $952.61
88313 613 601 $946.23
00142 23 16 $893.68
97803 273 272 $887.83
83090 208 207 $864.09
90685 3,062 3,021 $846.62
88185 191 179 $834.38
86735 302 297 $823.07
76942 768 752 $814.66
87102 1,341 1,306 $802.29
84075 27,972 26,855 $792.64
86015 380 378 $779.82
69200 142 136 $775.90
82785 408 407 $758.06
81513 26 26 $748.57
84163 693 688 $723.24
87563 132 132 $721.64
77072 26 26 $718.64
99152 6,217 5,855 $708.79
86141 228 227 $701.44
73120 55 54 $671.82
99231 Subsequent hospital care, per day, straightforward or low complexity 29 18 $665.43
88108 396 386 $662.37
89051 3,405 2,325 $660.09
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 2,889 2,563 $653.10
95886 4,377 4,352 $633.11
87177 678 658 $625.02
00811 18 16 $617.13
99238 Hospital discharge day management, 30 minutes or less 14 14 $613.50
94729 4,800 4,777 $612.28
76512 129 118 $587.26
0064A 16 16 $580.50
87901 25 25 $578.68
76870 2,634 2,590 $571.65
84681 118 117 $551.06
93926 12 12 $527.04
96368 3,982 3,388 $523.40
84145 1,570 1,522 $480.24
87255 279 277 $478.44
J2358 Injection, olanzapine, long-acting, 1 mg 68 51 $477.48
98940 64 41 $462.53
92226 287 278 $453.20
82977 225 210 $442.45
90846 Family psychotherapy without the patient present, 50 minutes 13 12 $441.34
11901 12 12 $437.74
92082 58 58 $434.36
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 87 84 $431.30
96101 76 76 $431.16
92610 12 12 $427.78
0053A 12 12 $402.30
12013 132 131 $399.14
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 27 27 $384.16
86645 262 260 $365.70
86308 3,159 3,122 $357.17
73600 282 267 $355.31
93225 12 12 $349.86
84295 430 339 $344.79
93320 2,271 2,245 $343.54
12002 2,009 1,979 $336.20
87015 157 151 $329.55
64494 862 750 $321.05
83930 2,202 2,044 $320.89
87075 1,128 1,090 $310.00
96136 449 448 $303.88
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion 166 98 $302.92
76519 13 13 $293.86
85240 101 97 $292.78
87906 25 25 $289.36
72220 96 95 $281.47
86618 117 116 $277.18
82077 8,360 7,948 $272.26
80158 47 24 $258.01
Q0112 All potassium hydroxide (koh) preparations 68 68 $249.86
73650 177 171 $247.80
64636 661 566 $236.49
72190 14 12 $229.20
96120 80 78 $220.46
96102 142 140 $220.46
87593 32 32 $217.16
84466 63 63 $213.85
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials 12 12 $209.96
96376 29,157 20,905 $206.69
74420 53 52 $205.58
85246 55 54 $202.32
11730 25 24 $196.29
84080 54 54 $194.80
99407 12 12 $191.96
99417 Prolong home eval add 15m 564 555 $185.60
Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) 18 18 $180.60
G0168 Wound closure utilizing tissue adhesive(s) only 14 14 $178.28
76937 882 817 $174.09
83718 51 51 $168.71
85245 43 42 $156.36
86777 92 87 $156.11
80185 620 513 $152.28
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 2,241 2,129 $150.81
76376 1,598 1,589 $146.50
84432 28 28 $145.46
80143 2,189 2,138 $141.96
85651 383 375 $138.82
90714 1,529 1,526 $129.60
76827 284 283 $121.88
88280 16 16 $120.64
80179 2,000 1,969 $120.31
86008 24 24 $120.06
77073 28 26 $118.56
36416 2,570 2,076 $111.36
76514 2,327 2,317 $110.23
86355 12 12 $104.85
80178 52 51 $104.32
85049 64 57 $103.92
82955 104 104 $103.41
88285 16 16 $97.00
82542 31 28 $96.74
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 4,031 3,895 $90.00
J2305 Injection, nitroglycerin, 5 mg 42 40 $83.21
86318 99 95 $79.62
85347 99 87 $79.40
G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) 83 83 $78.24
80202 21 12 $76.91
93325 2,655 2,610 $74.75
83935 158 145 $73.61
88142 12 12 $73.04
J1100 Injection, dexamethasone sodium phosphate, 1 mg 28,193 24,013 $72.85
91318 297 295 $72.33
86340 13 13 $68.64
77002 1,801 1,611 $67.84
84166 13 13 $65.06
J1836 Injection, metronidazole, 10 mg 485 362 $58.85
J3490 Unclassified drugs 14,275 10,897 $58.67
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) 1,021 1,009 $57.37
77001 331 322 $56.70
82787 13 13 $53.70
84590 12 12 $52.88
99153 Mod sedat endo service >5yrs 4,066 3,908 $52.54
84133 83 80 $50.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 610 524 $48.66
81002 244 233 $47.75
86256 27 27 $45.17
87046 16 16 $43.10
87045 16 16 $43.10
80175 31 28 $39.50
90687 392 391 $38.33
J1805 Injection, esmolol hydrochloride, 10 mg 252 252 $37.55
J1050 Injection, medroxyprogesterone acetate, 1 mg 6,599 6,589 $32.40
82652 12 12 $30.49
82985 12 12 $30.03
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 95 94 $28.28
90713 1,530 1,529 $28.14
29130 49 49 $27.98
J1885 Injection, ketorolac tromethamine, per 15 mg 16,397 14,916 $26.84
J1200 Injection, diphenhydramine hcl, up to 50 mg 14,007 11,834 $25.57
85307 12 12 $25.14
86778 27 26 $25.06
82310 13 13 $22.10
J2704 Injection, propofol, 10 mg 8,685 6,189 $22.05
J0131 Injection, acetaminophen, not otherwise specified,10 mg 2,870 2,737 $21.77
90633 21,210 21,153 $21.00
82945 373 360 $17.84
84157 399 387 $17.68
80165 13 12 $16.76
J3475 Injection, magnesium sulfate, per 500 mg 2,179 1,927 $15.52
90710 9,051 9,037 $14.00
87449 14 14 $13.01
88311 42 42 $12.99
94760 128 127 $12.19
82042 60 52 $11.35
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 2,568 1,168 $11.20
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 77 77 $10.94
J3010 Injection, fentanyl citrate, 0.1 mg 5,326 4,847 $10.23
J1920 Injection, labetalol hydrochloride, 5 mg 318 237 $9.72
88300 12 12 $8.72
90696 8,871 8,854 $7.00
90700 10,370 10,338 $7.00
87116 12 12 $6.83
82435 122 118 $6.48
J2405 Injection, ondansetron hydrochloride, per 1 mg 15,048 12,572 $6.40
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 67,328 57,644 $6.36
J2250 Injection, midazolam hydrochloride, per 1 mg 4,372 4,033 $6.06
J2470 Injection, pantoprazole sodium, 40 mg 449 337 $5.76
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) 1,088 1,078 $4.93
82272 2,104 2,078 $4.86
J1170 Injection, hydromorphone, up to 4 mg 1,638 1,276 $4.76
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 478 471 $3.95
82040 12 12 $3.01
J2060 Injection, lorazepam, 2 mg 564 475 $2.17
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 2,217 2,120 $2.13
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 8,365 8,113 $0.44
J0696 Injection, ceftriaxone sodium, per 250 mg 4,163 3,780 $0.24
J1030 Injection, methylprednisolone acetate, 40 mg 525 516 $0.03
V2632 Posterior chamber intraocular lens 1,741 1,637 $0.00
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg 319 265 $0.00
J1630 Injection, haloperidol, up to 5 mg 731 634 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 555 526 $0.00
90632 906 906 $0.00
J3411 Injection, thiamine hcl, 100 mg 459 410 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 254 251 $0.00
91307 2,237 2,088 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 559 526 $0.00
J0613 Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg 81 72 $0.00
G0268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing 943 932 $0.00
A4648 Tissue marker, implantable, any type, each 1,236 1,215 $0.00
95885 93 93 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 747 604 $0.00
J2785 Injection, regadenoson, 0.1 mg 551 544 $0.00
A9585 Injection, gadobutrol, 0.1 ml 143 141 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 1,114 1,029 $0.00
Q0247 Injection, sotrovimab, 500 mg 71 71 $0.00
J1817 Insulin for administration through dme (i.e., insulin pump) per 50 units 402 272 $0.00
91305 2,836 2,781 $0.00
90381 336 335 $0.00
J1790 Injection, droperidol, up to 5 mg 250 222 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 16 15 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 57 55 $0.00
83883 45 43 $0.00
96110 Developmental screening, with scoring and documentation, per standardized instrument 349 348 $0.00
91317 187 184 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 270 265 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 372 186 $0.00
J9267 Injection, paclitaxel, 1 mg 246 112 $0.00
94660 77 55 $0.00
96139 129 126 $0.00
J3480 Injection, potassium chloride, per 2 meq 319 263 $0.00
91315 270 270 $0.00
76377 69 68 $0.00
J0610 Injection, calcium gluconate (fresenius kabi), per 10 ml 18 16 $0.00
J0461 Injection, atropine sulfate, 0.01 mg 38 25 $0.00
74328 57 57 $0.00
J0690 Injection, cefazolin sodium, 500 mg 33 24 $0.00
Q0221 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg 13 13 $0.00
91301 247 243 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 264 260 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 13 12 $0.00
J1815 Injection, insulin, per 5 units 168 128 $0.00
91319 194 194 $0.00
91303 26 26 $0.00
C1766 Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away 14 13 $0.00
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation 16 16 $0.00
91306 15 15 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 14 12 $0.00
99156 13 13 $0.00
C1758 Catheter, ureteral 1,096 1,062 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 638 566 $0.00
90707 10,920 10,879 $0.00
51741 24 24 $0.00
58340 81 81 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 3,046 2,598 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 118 108 $0.00
90836 328 316 $0.00
92504 633 613 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 5,419 3,332 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 1,548 1,486 $0.00
J3489 Injection, zoledronic acid, 1 mg 204 198 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 3,288 2,968 $0.00
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 538 480 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 3,531 3,395 $0.00
C9113 Injection, pantoprazole sodium, per vial 5,330 3,773 $0.00
91312 1,926 1,925 $0.00
J2800 Injection, methocarbamol, up to 10 ml 382 354 $0.00
11101 19 13 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 222 218 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 740 736 $0.00
C1760 Closure device, vascular (implantable/insertable) 922 902 $0.00
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 1,373 1,357 $0.00
96133 409 409 $0.00
88302 12 12 $0.00
C1765 Adhesion barrier 723 721 $0.00
77012 25 25 $0.00
91300 11,520 10,390 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 91 91 $0.00
J1939 Injection, bumetanide, 0.5 mg 13 12 $0.00
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) 238 228 $0.00
95874 24 24 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 103 90 $0.00
A6209 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing 81 37 $0.00
J1171 Injection, hydromorphone, 0.1 mg 303 249 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 232 157 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 86 40 $0.00
J1756 Injection, iron sucrose, 1 mg 1,194 536 $0.00
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 174 172 $0.00
82365 25 25 $0.00
Q9956 Injection, octafluoropropane microspheres, per ml 26 26 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 159 130 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 132 120 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 124 108 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 1,198 1,190 $0.00
91308 496 473 $0.00
82375 203 200 $0.00
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries 71 71 $0.00
C1874 Stent, coated/covered, with delivery system 31 31 $0.00
93356 82 82 $0.00
C2625 Stent, non-coronary, temporary, with delivery system 42 41 $0.00
77003 62 57 $0.00
93321 13 13 $0.00
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg 542 301 $0.00
J1644 Injection, heparin sodium, per 1000 units 111 71 $0.00
73565 37 37 $0.00
17003 13 13 $0.00
90672 205 205 $0.00
A6021 Collagen dressing, sterile, size 16 sq. in. or less, each 33 27 $0.00
C1776 Joint device (implantable) 30 30 $0.00
82610 27 27 $0.00
77062 51 51 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 63 62 $0.00
86922 40 37 $0.00
Q0239 Injection, bamlanivimab-xxxx, 700 mg 12 12 $0.00
90655 24 24 $0.00
Q0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg 15 15 $0.00